Washington State House of Representatives Office of Program Research |
BILL ANALYSIS |
Health Care Committee | |
HB 1219
Brief Description: Authorizing a prescription drug purchasing consortium.
Sponsors: Representatives Cody, Schual-Berke, Morrell, Kessler, Simpson, Campbell, P. Sullivan, Williams, Chase, Dickerson, Quall, Kenney, O'Brien, Clibborn, Conway, Green, Lantz, Sells, Kagi, Ormsby, Wallace, McIntire, Upthegrove, Hasegawa and Kilmer; by request of Governor Gregoire.
Brief Summary of Bill |
|
Hearing Date: 1/25/05
Staff: Dave Knutson (786-7146).
Background:
Agencies that administer state purchased health care programs participate in an evidence-based
prescription drug purchasing program. Based on the findings of an independent pharmacy and
therapeutics committee, a preferred drug list is established and negotiations with pharmaceutical
manufacturers result in discounted prescription drug prices for state purchased health care
programs. Only state agencies participate in the evidence-based prescription drug purchasing
program.
Summary of Bill:
The administrator of the Health Care Authority will establish a prescription drug purchasing
consortium. The consortium may include, on a voluntary basis, local government, private
entities, labor organizations, and individuals without insurance, or who are underinsured for
prescription drug coverage. The Health Care Authority will impose fees on participants to cover
the administrative expense of operating the purchasing consortium. An eleven member advisory
committee is created to provide input on the implementation of the purchasing consortium.
Appropriation: None.
Fiscal Note: Requested on 1/20/05.
Effective Date: The bill takes effect 90 days after adjournment of session in which bill is passed.